Correction: Opiant Pharmaceuticals Corrects Error in Issuing Duplicate Press Release Today
January 21, 2022, 12:47 am
Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, reports that the company mistakenly reissued the press release this afternoon entitled,
